These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36893744)

  • 1. Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000.
    Ohta Y; Taida T; Kato J; Ogasawara S; Oyama Y; Mamiya Y; Nakazawa H; Horio R; Goto C; Takahashi S; Kurosugi A; Sonoda M; Shiratori W; Kaneko T; Yokoyama Y; Akizue N; Ishigami H; Koseki H; Okimoto K; Saito K; Saito M; Matsumura T; Nakagawa T; Masuya Y; Fukuda Y; Kitsukawa Y; Shimura H; Tsuyuguchi T; Kato N
    Digestion; 2023; 104(4):328-334. PubMed ID: 36893744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry.
    Singeap AM; Girleanu I; Diculescu M; Gheorghe L; Ciocîrlan M; Gheorghe C; Costache A; Tanțău A; Zaharie R; Goldis A; Gheonea D; Dobru D; Dumitru E; Prelipcean CC; Gîlcă-Blanariu GE; Moscalu M; Stanciu C; Trifan A
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):346-357. PubMed ID: 34375380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
    Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
    Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
    World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.
    Roberts H; Rai SN; Pan J; Rao JM; Keskey RC; Kanaan Z; Short EP; Mottern E; Galandiuk S
    Digestion; 2014; 90(2):122-9. PubMed ID: 25277851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
    Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A
    Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
    Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L;
    United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype.
    Singh B; Kedia S; Konijeti G; Mouli VP; Dhingra R; Kurrey L; Srivastava S; Pradhan R; Makharia G; Ahuja V
    Indian J Gastroenterol; 2015 Jan; 34(1):43-50. PubMed ID: 25663290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients.
    Adam H; Alqassas M; Saadah OI; Mosli M
    J Epidemiol Glob Health; 2020 Dec; 10(4):298-303. PubMed ID: 32959603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the risk factors for extraintestinal manifestations in inflammatory bowel diseases?
    Yeo MK; Park JH; Kang SH; Moon HS; Sung JK; Jeong HY; Kim JS
    Medicine (Baltimore); 2023 Mar; 102(9):e33031. PubMed ID: 36862909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB
    Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease.
    Severs M; van Erp SJ; van der Valk ME; Mangen MJ; Fidder HH; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Bolwerk C; Vermeijden JR; Pierik MJ; Siersema PD; Leenders M; van der Meulen-de Jong AE; Dijkstra G; Oldenburg B;
    J Crohns Colitis; 2016 Apr; 10(4):455-61. PubMed ID: 26721937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
    Ott C; Takses A; Obermeier F; Schnoy E; Müller M
    World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
    Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
    Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.
    Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A;
    Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.
    Jose FA; Garnett EA; Vittinghoff E; Ferry GD; Winter HS; Baldassano RN; Kirschner BS; Cohen SA; Gold BD; Abramson O; Heyman MB
    Inflamm Bowel Dis; 2009 Jan; 15(1):63-8. PubMed ID: 18626963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis.
    Jang HJ; Suh HR; Choi S; Hong SJ; Cho SM; Choi KH; Choe BH; Kang B;
    J Korean Med Sci; 2021 Nov; 36(44):e278. PubMed ID: 34783212
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.